Wisconsin Endocrine Society Meeting 2018

Brookfield, WI US
November 1, 2018

This program will address the subject of X-Linked Hypophosphatemia with an overview of the latest pathophysiology and mechanisms involved with this disorder along with possible treatment options.  This is a very important topic in Endocrine bone disorders and this program will provide new information and update practitioners on this disorder.  New information is always being gained and applied in novel ways. Even for the expert practitioners, it is a challenge to stay abreast of the latest information and intrepretation of findings and data.  In both an academic and private practice setting, updates on any new endocrine topics are always welcome. 

 

Target Audience

Endocrinologists
Fellows
Physician Assistants
Nurse Practioners
 

Learning Objectives

  • Understand the bone remodeling cycle;
  • and apply that knowledge to explain the mechanism of action and evaluate the efficacy of drugs used to treat low bone mass.
  • Be able to explain how the new biology of bone will help devise better therapies for bone loss including such problems as bone loss with long-term space travel.
Additional information

Contact

Name: 
Debra Warpechowski
Phone Number: 
+1 (414) 955-6724
Email: 
dwarpech@mcw.edu
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
09/24/2018
Course expires: 
01/18/2019
Event starts: 
11/01/2018 - 5:30pm CDT
Event ends: 
11/01/2018 - 8:30pm CDT
Cost:
$2.50
Add to calendar: 

5:30 - 6:30 PM  Registration and Cocktails
6:30 - 7:30 PM  Dinner
7:00 - 8:00 PM  "Basic Bone Biology: Bewildering Babble from a Bombastic Bonehead or Really Relevant?" presented by Dr. Karl Insogna
8:00 - 8:30 PM  Q & A and Closing Meeting

Fleming's Prime Steakhouse & Wine Bar
15665 W. Bluemound Road
Brookfield, WI 53005
United States

All persons in control of content have NO relevant financial relationships with the exception of:

NameCompanyRole
Roger Kulstad, MDNavitus Pharmacy and Therapeutics CommitteeConsultant
Karl Insogna, MDUltragenyxPI for Clinical Trial
Karl Insogna, MDUltragenyxScientific Advisory Board

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

 

 

 

 

ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The Medical College of Wisconsin and The Wisconsin Endocrine Society. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
 

AMA Credit Designation Statement:

The Medical College of Wisconsin designates this live activity for a maximum of 1.0  AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals. 

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Price

Cost:
$2.50
Please login or register to take this course.

Registration Fee = $35.00

Please note! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover.

A $2.50  non-refundable processing fee is assessed on all registrations. 

Cancellation policy: No refunds